Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5-110
SponsorJohannes Kepler University of Linz
About this trial
In this pilot study we want to investigate morphological features acquired by the novel image modality and gain information regarding disease pathomechanism, development and future possible influence on disease management for patients affected by those diseases.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age between 5 and 110 years
Ability to follow instructions during imaging procedure
Written Informed consent
Disqualifiers
Dementia
Inability to follow instructions during imaging procedure
Patients who do not give informed consent
Trial population
The participants will be selected by the Department of Ophthalmology at Kepler University Clinic Linz. All patients of the department scheduled for an outgoing appointment with regular examination in the time period of the study can be included in the study. Patients are being examined in the outgoing clinics with standard examinations. Additionally an image using the Zeiss Plex Elite 9000 Swept Source OCT is being performed. Patients of interest for this pilot study are patients with retinal, choroidal, vascular or glaucomatous changes.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
SS-OCT system Plex Elite 9000
Diagnostic testWe will use a commercially available SS-OCT system (Plex Elite 9000; Carl Zeiss Meditec).
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Morphological changes using Swept Source Optical Coherence Tomography
Morphological changes in retinal diseases provided by Swept Source Optical
Time frame
through study completion, an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov